BR9815745A - Combinações de inibidor de metaloproteinase de matriz estatina - Google Patents
Combinações de inibidor de metaloproteinase de matriz estatinaInfo
- Publication number
- BR9815745A BR9815745A BR9815745-0A BR9815745A BR9815745A BR 9815745 A BR9815745 A BR 9815745A BR 9815745 A BR9815745 A BR 9815745A BR 9815745 A BR9815745 A BR 9815745A
- Authority
- BR
- Brazil
- Prior art keywords
- statin
- combinations
- matrix metalloproteinase
- metalloproteinase inhibitor
- inhibitor
- Prior art date
Links
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 title abstract 2
- 229940121386 matrix metalloproteinase inhibitor Drugs 0.000 title 1
- 239000003771 matrix metalloproteinase inhibitor Substances 0.000 title 1
- 229940124761 MMP inhibitor Drugs 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- DFVFTMTWCUHJBL-BQBZGAKWSA-N statine Chemical compound CC(C)C[C@H](N)[C@@H](O)CC(O)=O DFVFTMTWCUHJBL-BQBZGAKWSA-N 0.000 abstract 1
- 208000019553 vascular disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7826598P | 1998-03-17 | 1998-03-17 | |
| PCT/US1998/024681 WO1999047138A1 (en) | 1998-03-17 | 1998-11-20 | Statin-matrix metalloproteinase inhibitor combinations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9815745A true BR9815745A (pt) | 2000-11-14 |
Family
ID=22142950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9815745-0A BR9815745A (pt) | 1998-03-17 | 1998-11-20 | Combinações de inibidor de metaloproteinase de matriz estatina |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1063991A1 (es) |
| JP (1) | JP2002506818A (es) |
| KR (1) | KR20010041916A (es) |
| AR (1) | AR018113A1 (es) |
| AU (1) | AU1591699A (es) |
| BR (1) | BR9815745A (es) |
| CA (1) | CA2309588A1 (es) |
| CO (1) | CO5070670A1 (es) |
| GT (1) | GT199900039A (es) |
| HN (1) | HN1999000029A (es) |
| MY (1) | MY140504A (es) |
| NZ (1) | NZ505994A (es) |
| PA (1) | PA8469001A1 (es) |
| PE (1) | PE20000348A1 (es) |
| SV (1) | SV1999000026A (es) |
| UY (1) | UY25436A1 (es) |
| WO (1) | WO1999047138A1 (es) |
| ZA (1) | ZA992106B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
| GB0100761D0 (en) | 2001-01-11 | 2001-02-21 | Biocompatibles Ltd | Drug delivery from stents |
| AU2005315608B2 (en) | 2004-12-15 | 2011-03-31 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and HMG CoA reductase inhibitors |
| JP2009514851A (ja) * | 2005-11-08 | 2009-04-09 | ランバクシー ラボラトリーズ リミテッド | （３ｒ，５ｒ）−７−［２−（４−フルオロフェニル）−５−イソプロピル−３−フェニル−４−［（４−ヒドロキシメチルフェニルアミノ）カルボニル］−ピロール−１−イル］−３，５−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法 |
| WO2010005389A1 (en) * | 2008-07-11 | 2010-01-14 | Forskarpatent I Syd Ab | Oxidized ldl specific antibody-fusion and conjugated proteins |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL123902A (en) * | 1995-11-02 | 2003-01-12 | Warner Lambert Co | PHARMACEUTICAL COMPOSITION FOR REGULATING LIPID CONCENTRATION CONTAINING ACYL-CoA CHOLESTEROL O-ACYLTRANSFERASE (ACAT) INHIBITOR AND AN HMG-CoA REDUCTASE INHIBITOR |
| ES2167733T3 (es) * | 1996-05-17 | 2002-05-16 | Warner Lambert Co | Inhibidores de metaloproteinasa matricial de bifenilsulfonamida. |
| CA2263886A1 (en) * | 1996-12-09 | 1998-06-18 | Warner-Lambert Company | Method for treating and preventing heart failure and ventricular dilatation |
| TW536540B (en) * | 1997-01-30 | 2003-06-11 | Bristol Myers Squibb Co | Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe |
| GT199800126A (es) * | 1997-08-29 | 2000-01-29 | Terapia de combinacion. |
-
1998
- 1998-11-20 KR KR1020007010223A patent/KR20010041916A/ko not_active Ceased
- 1998-11-20 BR BR9815745-0A patent/BR9815745A/pt not_active Application Discontinuation
- 1998-11-20 EP EP98960279A patent/EP1063991A1/en not_active Withdrawn
- 1998-11-20 AU AU15916/99A patent/AU1591699A/en not_active Abandoned
- 1998-11-20 JP JP2000536378A patent/JP2002506818A/ja active Pending
- 1998-11-20 WO PCT/US1998/024681 patent/WO1999047138A1/en not_active Ceased
- 1998-11-20 NZ NZ505994A patent/NZ505994A/xx unknown
- 1998-11-20 CA CA002309588A patent/CA2309588A1/en not_active Abandoned
-
1999
- 1999-02-24 AR ARP990100751A patent/AR018113A1/es unknown
- 1999-03-15 MY MYPI99000951A patent/MY140504A/en unknown
- 1999-03-16 CO CO99016109A patent/CO5070670A1/es unknown
- 1999-03-16 SV SV1999000026A patent/SV1999000026A/es not_active Application Discontinuation
- 1999-03-16 ZA ZA9902106A patent/ZA992106B/xx unknown
- 1999-03-16 PE PE1999000217A patent/PE20000348A1/es not_active Application Discontinuation
- 1999-03-16 HN HN1999000029A patent/HN1999000029A/es unknown
- 1999-03-16 PA PA19998469001A patent/PA8469001A1/es unknown
- 1999-03-16 GT GT199900039A patent/GT199900039A/es unknown
- 1999-03-16 UY UY25436A patent/UY25436A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999047138A1 (en) | 1999-09-23 |
| MY140504A (en) | 2009-12-31 |
| ZA992106B (en) | 1999-09-30 |
| UY25436A1 (es) | 2001-10-25 |
| CO5070670A1 (es) | 2001-08-28 |
| KR20010041916A (ko) | 2001-05-25 |
| EP1063991A1 (en) | 2001-01-03 |
| PE20000348A1 (es) | 2000-05-22 |
| GT199900039A (es) | 2000-09-06 |
| PA8469001A1 (es) | 2002-09-17 |
| AR018113A1 (es) | 2001-10-31 |
| NZ505994A (en) | 2003-10-31 |
| JP2002506818A (ja) | 2002-03-05 |
| HN1999000029A (es) | 1999-09-29 |
| SV1999000026A (es) | 2000-01-18 |
| AU1591699A (en) | 1999-10-11 |
| CA2309588A1 (en) | 1999-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0113669A (pt) | Inibidores da desacetilase | |
| BR9809793A (pt) | Monoésteres de probucol para o tratamento de doença inflamatória e cardiovascular | |
| BR9805544C1 (pt) | Uso de um composto. | |
| AR032086A1 (es) | Combinaciones de farmacos | |
| BR0212014A (pt) | Uso de derivados do ácido hidroxâmico inibidores da enzima histone deacetilase | |
| PA8506101A1 (es) | Uso de un compuesto acat para fabricar una composicion farmaceutica | |
| FI940012A0 (fi) | Aryylisulfonamidosubstituoidut hydroksaamihapot | |
| BR9812753A (pt) | Combinação farmacêutica, uso da mesma, processo para tratamento de uma doença inflamatória, e, composição farmacêutica | |
| MA26812A1 (fr) | Pyrimidine-2,4,6-triones inhibitrices de metalloproteinases | |
| EP1496906A4 (en) | HEMMER OF ACT ACTIVITY | |
| EP1494675A4 (en) | HEMMER OF ACT ACTIVITY | |
| BR0317715A (pt) | Composições e processos de uso de collajolie | |
| ATE266000T1 (de) | Hydroxamsäure- und carbonsäure-derivate mit mmp und tnf hemmender wirkung | |
| BR9807655A (pt) | Uso de inibidores de lipase gastrintestinal. | |
| BR9711194A (pt) | Uso de agente quelante clioquinol para a fabricação de uma composição farmacêutica para o tratamento de doença de alzheimer. | |
| NO973035D0 (no) | Hydroksaminsyre-holdige inhibitorer for matriks-metallproteaser | |
| EE200000093A (et) | Agrekanaasi ja maatriksmetalloproteinaaside uudsed inhibiitorid artriidi käitlemiseks | |
| BR9812371A (pt) | Tratamento de distúrbio de conduta | |
| ATE266634T1 (de) | Cyclobutyl-aryloxysulfonylamin- hydroxamsäurederivate | |
| BR9812357A (pt) | Tratamento de distúbio oposicional desafiador | |
| FR2834890B1 (fr) | Composition pharmaceutique orodispersible d'agomelatine | |
| BR9714142A (pt) | Uso de inibidores de metaloproteìnases matriciais para tratamento de distúrbios neurológicos e promoção de cicatrização de feridas | |
| EA200401183A1 (ru) | Применение ингибиторов il-18 в качестве диагностического маркера | |
| BR9804027A (pt) | Novos beta-ceto ésteres | |
| ATE448774T1 (de) | Kosmetische zusammensetzung enthaltend ein siegesbeckia extrakt und ein lipopeptid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DE INT.CL: A61K 45/06, A61P 9/10 Ipc: A61K 31/40 (2008.04) |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI. |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |